Cellnovo Group announced that it is building a second large-scale production line for the manufacture of its insulin cartridges. This announcement comes as the first production line, at a Flex facility in Austria, ramps up to full production capacity. The second production line, to be built in a Flex facility in Romania, will have the same annual production capacity as the first line, at 600,000 cartridges per year. The Flex facility in Romania was selected for its cost efficiencies, which will significantly reduce the overall cost of goods sold of company’s insulin cartridges. The completion of the project is expected in first half 2018.